Stay updated on PF-07901800 Study in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the PF-07901800 Study in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-07901800 Study in Hematologic Malignancies Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.6%
    Check dated 2025-05-08T13:07:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    1%
    Check dated 2025-05-01T05:37:36.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The webpage has added a section with helpful links provided by Pfizer, specifically directing users to obtain contact information for a study center nearby.
    Difference
    1%
    Check dated 2025-04-23T22:21:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a more detailed description of the Phase 1a/1b trial of PF-07901800 (TTI-621) for hematologic malignancies, including specific phases and cohorts involved in the study. Additionally, the revision number has been updated to v2.15.0.
    Difference
    18%
    Check dated 2025-04-16T14:43:08.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    1%
    Check dated 2025-04-09T09:50:34.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in focus from Lymphosarcoma to Multiple Myeloma, indicating a shift in the content's emphasis. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.5%
    Check dated 2025-04-01T23:35:12.000Z thumbnail image

Stay in the know with updates to PF-07901800 Study in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-07901800 Study in Hematologic Malignancies Clinical Trial page.